Picture of an eye showing symptoms of thyroid eye disease including irritation, redness, dryness, proptosis (bulging eye), and slight lid retraction that creates a startled look.

This study assesses the risk of developing thyroid eye disease (TED) after mRNA COVID-19 vaccination in patients with thyroid dysfunction.

bit.ly/cjo_thyroid-...

#Ophthalmology #ThyroidEyeDisease

Amgen scores with new thyroid eye disease formulation Can Amgen's subcutaneous version of Tepezza inject renewed growth into the thyroid eye disease blockbuster?

#Amgen's Tepezza became the first drug approved by the FDA for #thyroideyedisease (TED) in 2020, and the company is now looking to extend its role with a new, more patient-friendly formulation.

pharmaphorum.com/news/amgen-s...

Bar graph titled "Figure 1. Rate of Human Papillomavirus (HPV) in Thyroid Eye Disease (TED) Cases vs Autoimmune Hyperthyroidism (AH) Controls". The Y axis is "Rate of diagnosis, %", comparing "With TED" and "Control" across LR-HPV and HR-HPV diagnoses before and after AH.

Low-risk human papillomavirus (HPV) was more prevalent in patients with #ThyroidEyeDisease (TED) prior to autoimmune hyperthyroidism, and TED patients with HPV had higher rates of orbital decompression.

ja.ma/3ZYhPEh

Bar graph: HPV rates in Thyroid Eye Disease (TED) vs. Autoimmune Hyperthyroidism (AH). X-axis: LR-HPV/HR-HPV diagnosis before/after AH. Y-axis: Rate of diagnosis (%). TED has higher LR-HPV before AH, but similar rates after. HR-HPV diagnosis is higher after AH.

Low-risk human papillomavirus (HPV) was more prevalent in patients with #ThyroidEyeDisease (TED) prior to autoimmune hyperthyroidism, and TED patients with HPV had higher rates of orbital decompression.

ja.ma/4aglEKU

The Thyroid Eye Disease Charitable Trust - TEDct We exist to improve the lives of those with thyroid eye disease by developing a supportive community of patients and professionals.

👁️‍🗨️ TEDct supports people with Thyroid Eye Disease (TED) through info, resources & a patient forum. Raising awareness, sharing guidance & connecting the TED community. 💙 #ThyroidEyeDisease #TEDAwareness #TEDPatientSupport #thyroidHealthCharity #Gravesdisease

Point Counter-Point -Is the Rundle Curve Still Valuable in Managing Thyroid Eye Disease?: Journal of Neuro-Ophthalmology
Article:https://bit.ly/JNO_Rundle
#brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #thyroid #thyroideyedisease #ted @UMNews @MethodistHosp

First day back doing the school run post operation. I'm completely wrecked.

I think I'm definitely past peak bruising. So hopefully I'll be looking more like myself soon.

#ThyroidEyeDisease

Post operative photo

Good news. The operation went well, and I can see. 🥳

#GravesDisease #Thyroid #ThyroidEyeDisease #TED

Graves' Disease and Its Impact on Eye Health Graves’ disease is an autoimmune thyroid disorder often linked with Thyroid Eye Disease. Learn its history, symptoms, treatments, and emerging therapies.

Graves’ disease is an autoimmune condition that causes the thyroid to become overactive, and it can also lead to a serious complication called Thyroid Eye Disease (TED). Here’s a quick look at what it is, how it affects the eyes, and the latest approaches to care.

#GravesDisease #ThyroidEyeDisease

TED Community Organization | Thyroid Eye Disease Education & Emotional Support The TED Community Organization is a 501c3 nonprofit dedicated to Education, Support and Connection for patients with Thyroid Eye Disease. And a trusted source of collaboration among TED researchers, h...

Awareness matters — we’re proud to highlight the work of the TED Community Organization, a 501(c)(3) nonprofit that educates, supports, and connects everyone affected by Thyroid Eye Disease.
Learn more and join the movement: tedcommunity.org
#TEDAwarenessWeek #ThyroidEyeDisease

Thyroid Eye Disease | Information on Symptoms, Treatment, and Resources Discover how Thyroid Eye Disease can affect you or your loved one and find information on signs and symptoms, treatment, and specialists.

LISTEN TO YOUR EYES. This week is Thyroid Eye Disease (TED) Awareness Week — November 10–16.
💙 Visit to learn more: www.thyroideyes.com
#ThyroidEyeDisease #TEDAwarenessWeek
@amgen.bsky.social

What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient | Ophthalmology Times - Clinical Insights for Eye Specialists Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient: www.ophthalmologytimes.com/view/what-im...
#ThyroidEyeDisease #TEDAwarenessWeek #HealthcareAdvocacy #PatientVoices

Tepezza for #thyroideyedisease approved in UK but still under consideration by NICE. unfortunately it seems it may have severe side effects, like hearing loss?

I'll talk about #Sjogrens overlapping with TED in my essay "The Sicca Messenger", including what I've learned, how I'm coping, what I do.

Thyroid Eye Disease: Active Phase Treatments - TEDct Here, we’ll look at the current treatments available in the UK to help manage active TED, along with an overview of possible side effects.

I sympathise with all the patients with #ThyroidEyeDisease #TED

Only partially satisfactory surgery + lack of effective drugs = huge impact on appearance / confidence, echoed by the character Amina in one of my short stories, "Teeth of Love".

Here some real cases:

tedct.org.uk/patient-info...

#thyroideyedisease #endocrinology #rheumatology #nhs | Nima Ghadiri In Harmonious Orbit: When Physicians and Surgeons Align... Orbital inflammation sits at the crossroads between medical and surgical ophthalmology. These complex conditions (which included thyroid eye...

Read more here:

www.linkedin.com/posts/nimagh...

#OrbitalInflammation
#ThyroidEyeDisease
#Inflammation

In Harmonious Orbit-When Physicians & Surgeons Align

At Aintree Hospital @nhsuhlg.bsky.social our joint clinic unites physicians and surgeons to manage complex orbital inflammation & #thyroideyedisease

A joint approach means rapid decisions, holistic care & optimal patient outcomes

#Ophthalmology

IGF-1R Antibody Reduces Thyroid Eye Disease Signs, Improves Quality of Life - Ophthalmology Advisor Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.

#AAO2025: Treatment with an intravenously delivered, anti-insulin-like growth factor-1 receptor (IGF-1R) antibody can reduce signs of thyroid eye disease (#TED) and improve quality of life.

Read here: https://bit.ly/3LrozWR

#Ophthalmology #IGF1R #ThyroidEyeDisease

Study: Veligrotug Improves Life Quality in TED People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved quality of life after 15 weeks of treatment.

Dr. Michael Yen and other experts talk about how insulin-like growth factor-1 receptor IV infusions can help patients with thyroid eye disease. https://wb.md/4qrDLDz #ThyroidEyeDisease

At this #CME symposium, Drs. Wendy Lee, Gary Lelli Jr. and Daniel Rootman will review evidence-based diagnostic strategies for the accurate and timely diagnosis of #thyroideyedisease!

Register here>> events.vindicocme.com/en/15kYU86/g...

#ASOPRS

3 Things You Should Know About Early Treatment Intervention for TED | Ophthalmology Times - Clinical Insights for Eye Specialists Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Sophie Liao, MD & Cecelia Koetting, OD share 3 key insights on early treatment for thyroid eye disease in a new Ophthalmology Times podcast. 👁️

Listen: https://bit.ly/4304NaW

#ThyroidEyeDisease #Ophthalmology #MedSky

Don’t miss this meeting at #ASOPRS to review evidence-based diagnostic strategies for the accurate and timely diagnosis of #thyroideyedisease.

Register Today>> events.vindicocme.com/en/15kYU86/g...

Great to represent patients alongside TEDct and our fabulous trustees at the EUGOGO global symposium on thyroid eye disease. #EUGOGO2025 #ted #ThyroidEyeDisease

The recordings from our recent TED online patient event are now available to watch from our homepage.

We also share results of a recent survey highlighting TED’s devastating impact on quality of life.

🔗 tinyurl.com/m2s45hxs
#ted #ThyroidEyeDisease #EUGOGO2025 @thyroidbritish.bsky.social

The Circle of Sight 👁️🦁☀️Discover the latest in #thyroideyedisease treatment with us at #ASOPRS.

Register now >> events.vindicocme.com/en/15kYU86/g...

Meet the Expert at ESICON 2025! 🌟
ESICON 2025 is honoured to have Dr. George J. Kahaly (Germany) shares his insights on Thyroid Eye Disease.

Register Now:https://rxregistrations.com/esicon2025/
🗓 4-7 September 2025

#ESICON2025 #ThyroidEyeDisease #Endocrinology #MedicalConference

Veligrotug Safe, Efficacious for Active TED Veligrotug demonstrated significant improvements in proptosis, diplopia, and clinical activity score among patients with active thyroid eye disease.

From #ENDO2025: Veligrotug vs placebo was associated with significant improvements in #proptosis, #diplopia, and clinical activity score in active #ThyroidEyeDisease.

@endocrinesociety.bsky.social @uwmedicine.bsky.social @bcmhouston.bsky.social @keck.usc.edu @stanfordmedicine.bsky.social

Alumis' Acelyrin merger back on track after shareholders unswayed by activist investor Acelyrin’s shareholders have decided to power ahead with a planned merger with immune-mediated disease specialist Alumis, despite the best efforts of an activist investor to derail the deal.

Acelyrin's Board finally approve merger with Alumis after activist shareholder's intervention, hopefully securing the continued clinical testing of lonigutamab for thyroid eye disease. #thyroideyedisease

Amgen’s Tepezza granted marketing authorisation in the UK - PharmaTimes Teprotumumab approved as first targeted treatment for thyroid eye disease

#thyroideyedisease #TED #Amgen #Tepezza #Teprotumumab #Gravesophthalmopath #GravesEyeDisease #autoimmunedisorder #overactivethyroid #marketingauthorisation #MHRA #immunotherapy #insulinlikegrowthfactor1receptor #IGF1R #phase3OPTICtrial #OPTICtrial #proptosis
pharmatimes.com/news/amgens-...

Thyroid Eye Disease Education Hub Thyroid Eye Disease (TED)

Has TED changed the way you see yourself? You are not alone and we are here to help. Embracing this unique journey is self-empowerment.
Check out our TED resources here: ghlf.org/thyroid-eye-...
#TEDAwareness #EmbraceYourself #ThyroidEyeDisease

Can Tepezza treat eye bulging and double vision? Official answer: Yes, Tepezza is very good at treating eye bulging and double vision caused by thyroid eye disease with 8 out of 10...

#Tepezza delivers impressive results for thyroid eye disease, with 82.9% of patients experiencing reduced eye bulging compared to placebo. It also enhances double vision, visual ability, and appearance. #ThyroidEyeDisease